Related references
Note: Only part of the references are listed.Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods
Osama A. Sorour et al.
SURVEY OF OPHTHALMOLOGY (2023)
Intravitreal dexamethasone insert in diabetic macular edema super-refractory to anti-vascular endothelial growth factor therapy
Carl S. Wilkins et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
Justus G. Garweg et al.
ADVANCES IN THERAPY (2022)
Fluctuations in macular thickness in patients with diabetic macular oedema treated with anti-vascular endothelial growth factor agents
Victoria Y. Wang et al.
EYE (2022)
Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic Review
Ana Maria Dascalu et al.
CURRENT PHARMACEUTICAL DESIGN (2022)
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
Masahiko Sugimoto et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Chirag D. Jhaveri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial
Takao Hirano et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2021)
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045 Systematic Review and Meta-analysis
Zhen Ling Teo et al.
OPHTHALMOLOGY (2021)
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew R. Starr et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders
Ali Salimi et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2021)
Efficacy of Conversion to Aflibercept for Diabetic Macular Edema Previously Refractory to Bevacizumab or Ranibizumab: A Meta-analysis of High-Quality Nonrandomized Studies
Kang Xiao et al.
ANNALS OF PHARMACOTHERAPY (2020)
Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema
Ehsan Rahimy et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2020)
Two-year outcomes of the treat-and-extend regimen using aflibercept for treating diabetic macular oedema
Yu Cheol Kim et al.
SCIENTIFIC REPORTS (2020)
Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept - A Retrospective Cohort Study
Christoph Kern et al.
CLINICAL OPHTHALMOLOGY (2020)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial
Neil M. Bressler et al.
JAMA OPHTHALMOLOGY (2018)
Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T
Neil M. Bressler et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2018)
Current management of diabetic tractional retinal detachments
Michael W. Stewart et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2018)
Aflibercept in the treatment of diabetic macular edema: a review and consensus paper
Teresio Avitabile et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)
Intravitreal Aflibercept for Diabetic Macular Edema 148-Week Results from the VISTA and VIVID Studies
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intravitreal Aflibercept for Diabetic Macular Edema 100-Week Results From the VISTA and VIVID Studies
David M. Brown et al.
OPHTHALMOLOGY (2015)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Proposed Lexicon for Anatomic Landmarks in Normal Posterior Segment Spectral-Domain Optical Coherence Tomography
Giovanni Staurenghi et al.
OPHTHALMOLOGY (2014)
Expression of VEGF-A, Otx Homeobox and p53 Family Genes in Proliferative Vitreoretinopathy
Claudio Azzolini et al.
MEDIATORS OF INFLAMMATION (2013)
The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema
Diana V. Do et al.
OPHTHALMOLOGY (2011)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Visual impairment and blindness in Europe and their prevention
I Kocur et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)